Identification of Pharmacological Chaperones for Gaucher Disease and Characterization of Their Effects on β-Glucocerebrosidase by Hydrogen/Deuterium Exchange Mass Spectrometry-Reference-Cited by-同舟云学术

Identification of Pharmacological Chaperones for Gaucher Disease and Characterization of Their Effects on β-Glucocerebrosidase by Hydrogen/Deuterium Exchange Mass Spectrometry

Published:2008-11-03 Issue:16 Volume:9 Page:2650-2662
ISSN:1439-4227
Container-title:ChemBioChem
language:en
Short-container-title:ChemBioChem

Author:

Tropak Michael B.,Kornhaber Gregory J.,Rigat Brigitte A.,Maegawa Gustavo H.,Buttner Justin D.,Blanchard Jan E.,Murphy Cecilia,Tuske Steven J.,Coales Stephen J.,Hamuro Yoshitomo,Brown Eric D.,Mahuran Don J.

Publisher

Wiley

Subject

Organic Chemistry,Molecular Biology,Molecular Medicine,Biochemistry

Reference59 articles.

1. Pharmacotherapeutic strategies using small molecules for the treatment of glycolipid lysosomal storage disorders

2. Genetics of the Sphingolipidoses

3. Analysis and Classification of 304 Mutant Alleles in Patients with Type 1 and Type 3 Gaucher Disease

4. Hematologically important mutations: Gaucher disease

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GBA1-Associated Parkinson’s Disease Is a Distinct Entity;International Journal of Molecular Sciences;2024-06-28

2. Development of quantitative high-throughput screening assays to identify, validate, and optimize small-molecule stabilizers of misfolded β-glucocerebrosidase with therapeutic potential for Gaucher disease and Parkinson’s disease;2024-03-27

3. GBA1 Variants and Parkinson’s Disease: Paving the Way for Targeted Therapy;Journal of Movement Disorders;2023-09-30

4. Future Imaging in Dementia;Seminars in Nuclear Medicine;2021-05

5. Second-Generation Pharmacological Chaperones: Beyond Inhibitors;Molecules;2020-07-09